Updates & Insights

CAMK2-Related Neurodevelopmental Disorders: A Giving Smarter Guide

Schizophrenia Research and Care: Assessment of Challenges and Opportunities

SPARC conducted an extensive literature review with insights from over 70 experts, to find five areas where philanthropy can drive meaningful progress in schizophrenia research and care.

Milken Institute Global Conference 2025 panel: Fact or Fiction: Fostering Trust in Science

Public trust in science is vital yet threatened by misinformation and low health literacy. This session explores cross-sector strategies to rebuild confidence through transparency and effective communication.

Milken Institute Global Conference 2025 panel: Advancing Paths to Precision Brain Health

This panel at the 2025 Milken Institute Global Conference discusses innovative techniques to diagnose and treat neurological conditions, including leveraging AI and big data.

Milken Institute Global Conference 2025 panel: Expanding Solutions to Improve Mental Health

Mental health care requires bold, cross-sector collaboration that extends beyond traditional systems. This panel explores how collective action can reduce stigma, expand access, and drive scalable, transformative solutions for mental health worldwide.

How Philanthropy Can Support a Community-Centered Biomedical Research Ecosystem to Achieve Health Equity

Health equity ensures everyone has a fair chance at good health, yet systemic barriers in research leave many communities behind. Philanthropy can help close these gaps by investing in inclusive research, community engagement, and workforce diversity.

The Value of Collaboration in Rare Disease Research

Childhood brain cancers are among the rarest and most difficult to treat, but new models of collaboration are changing what’s possible. This article explores how philanthropy, advocacy, and cross-sector partnerships are breaking down barriers and accelerating progress toward better treatments.

BD² 2024 Milestone Report

In 2024, major strides were made in accelerating bipolar disorder research. This report highlights BD²’s progress and the growing collaboration aimed at improving outcomes for people living with the condition.

Milken SPARC, partners commit $70 million to underinvested diseases

SPARC, in collaboration with its philanthropic partners, has announced commitments totaling $70 million to bolster research into historically underinvested diseases.

Milken Institute Future of Health Summit 2024 panel: Catalysts of Change: Philanthropy, Advocacy, and Innovation in Rare Disease Research

Collaboration across the rare disease community has driven major breakthroughs in diagnosis and treatment. Innovative, data-driven approaches pioneered in this field are now shaping a new model for medical research—one that could improve outcomes and reduce costs across all diseases.

Harnessing Community Power: Driving Health Equity Research

Achieving health equity requires centering communities in biomedical research. This panel explores how collaboration across sectors can empower communities to shape research and drive lasting change.

Milken Institute Future of Health Summit 2024 panel: Brain Check: Innovations in Prevention, Detection, and Intervention for Neurodegenerative Disease

This 2024 Future of Health panel explores how lifestyle choices and early screening can help prevent neurodegenerative diseases, alongside new advances in dementia diagnostics and treatments.